Miscarriage Preventing Herbal Medicines and the Risk of Birth Defects: a Population-based Cohort Study

NCT06048276 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200000

Last updated 2024-05-07

No results posted yet for this study

Summary

Using data from a population-based medicine use cohort in Xiamen, China, this retrospective cohort study will investigate whether herbal medicines used to prevent miscarriage are associated with increased risk of birth defects.

Conditions

Interventions

DRUG

Herbal medicines (e.g., Yunkang granules, Duzhong granules)

Herbal medicines (e.g., Yunkang granules, Duzhong granules) exposure at the early gestation.

Sponsors & Collaborators

  • Xiamen Health Commission

    collaborator UNKNOWN
  • Xiamen Health and Medical Big Data Center

    collaborator UNKNOWN
  • West China Hospital

    lead OTHER

Principal Investigators

  • Xin Sun, PHD · Chinese Evidence-based Medicine Center, West China Hospital, Sichuan

Eligibility

Min Age
15 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-10-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06048276 on ClinicalTrials.gov